The RAPID (Rapid Access Prostate Imaging and Diagnosis) Pathway is using the findings from cutting edge research to identify those men who are most at risk of having prostate cancer and who require a further investigative biopsy. This involves implementing a shortened diagnostic pathway for men with suspected prostate cancer (raised PSA or abnormal DRE) and trialing fusion technology for a revolutionary biopsy procedure.
Men with suspected prostate cancer will have a multi-parametric MRI and recieve the results with a specialist clinican during their first hospital appointment. Those men who have no or low grade prostate cancer may then be safely discharged to their GP without further investigation. Those men who do require further investigation will be offered a transperineal fusion biopsy.
Imperial Prostate were among the first of the urology centres in the United Kingdom to adopt multi-parametric MRI as a first-line investigative tool.
A multi-parametric MRI is made up of up to three different types of MRI scan which provides our expert radiologists with a clearer picture of whats going on inside the prostate.
Clinicians are then able to identify the precise location of any suspicious areas, as well as ruling out the need for some men to have a biopsy.
MRI targeted biopsy is a new technique in prostate surgery which was developed by the Imperial Prostate team. It offers advantages over previous blind biopsies which often missed disease when taking random samples
The Imperial Prostate team conducts all biopsies through the perineum rather than the rectum which reduces the risk of infection